Objective: The aim of the work described here was to measure the role of psychopathological features, specifically impulsivity and depression, in suicidality in patients with temporal lobe epilepsy (TLE). Methods: Neuropsychiatric evaluation of 66 outpatients with TLE was performed with the following instruments: a structured clinical interview (Mini International Neuropsychiatric Interview Plus), the Barratt Impulsiveness Scale, the Hamilton Anxiety Scale, the Beck Depression Inventory, and the Brief Psychiatric Rating Scale. Results: A current Axis I psychiatric diagnosis, mainly mood and anxiety disorders, was assigned to 37 subjects (56.1%) Presence of suicide risk was identified in 19 patients (28.8%), and 14 (21.2%) had attempted suicide. Frequency of seizures (P = 0.012), current major depression (P = 0.001), and motor impulsivity (P = 0.005) were associated with suicide risk on univariate analysis. Logistic regression stressed the main relevance of major depression (OR = 12.82, 95% CI = 2.58-63.76, P = 0.002) and motor impulsivity (OR = 1.21, 95% CI = 1.06-1.38, P = 0.005) to suicide risk. Conclusion: Depression has a major influence on suicidality in epilepsy. Motor impulsivity is also relevant and may be an important component of depression in TLE associated with suicide risk.
Introduction
Epilepsy and suicide are two prevalent health conditions that may be associated [1] . A number of recent reports have pointed out that patients with epilepsy, mainly temporal lobe epilepsy (TLE), have an increased risk of suicide [2] [3] [4] [5] . A meta-analysis using standardized mortality ratios (SMRs) conducted by Bell and co-workers [2] identified that deaths by suicide in people with epilepsy were three times higher than expected in the general population (SMR = 3.3, 95% CI 2.8-3.7). These authors also highlighted increased rates of death by suicide in patients with TLE (SMR 6.6, 95% CI 1.8-16.8) and after temporal lobectomy (SMR 13.9, 95% CI = 8.9-20.7) [2] . Conversely, people who attempt suicide appear to be more prone to develop seizures, pointing to possible bidirectional mechanisms [6] .
Limbic epileptogenic areas in TLE, such as the amygdala, are involved in social behaviors, including impulse control, anxiety, and emotional memory [7] . Altered serotonergic neurotransmission has been described in epilepsy, depression, and impulsive and suicidal behavior [8] . A putative association between impulsivity, suicide, and mood disorders has also been reported in the literature [9, 10] . In line with this, psychiatric disorders, particularly depression and anxiety, are associated with suicidality in epilepsy [1, 11] . Moreover, patients with suicidal behavior often have problems in cognitive inhibition [8] , and abnormalities in serotoninergic projections to prefrontal cortex (PFC) seem to play a role in this executive impairment. Recently, Espinosa et al. found that executive dysfunction has a major influence on suicide risk and attempts in TLE [12] . Barratt et al. proposed that neurophysiological substrates of seizures may also predispose to a hyperexcitable neuronal state responsible for impulsivity in epilepsy [13] .
There are limited data in the literature on factors associated with suicide and epilepsy in different cultural and socioeconomic settings [12] . Such studies can throw light on the pathogenesis of suicide and might help elucidate the extent to which epilepsy and psychopathological factors account for suicide risk. Therefore, we conducted a cross-sectional study in Brazil to assess clinical and psychopathological features associated with suicidality in TLE, as well as to measure the effect of impulsivity and depression. 
Methods
After previous written informed consent and approval by the local ethics committee, 66 outpatients recruited from the Epilepsy Section of the Hospital das Clínicas, Universidade Federal de Minas Gerais, Brazil, were evaluated. This epilepsy section is a specialized tertiary service that treats more than 1000 patients with different epilepsy syndromes.
Psychiatric Axis I diagnoses were established using the Mini International Neuropsychiatric Interview (MINI) Plus, Version 5.0.0. [14, 15] . This instrument accesses lifetime and current psychiatric disorders. Of note, the term current was used here to indicate that the patient has the disease at present, regardless of his or her past history. Lifetime means that the patient has had at least one episode of the disorder during his or her life, even those whose single episode is still present. Suicidality was evaluated with the suicide module of the MINI Plus, which consists of six items (0-33 points) that assess lifetime suicide attempts and the presence and level (1-5 low, 6-9 moderate, N9 high) of current suicide risk [16] . In this study we established the presence of suicide risk if the patient scored ≥1 point on the MINI Plus suicidality module. In addition, the Beck Depression Inventory (BDI, total score range: 0-63) [17, 18] , Hamilton Anxiety Scale (HAM-A, total score range: 0-56) [19, 20] , and Brief Psychiatric Rating Scale (BPRS, total score range: 0-108) [21, 22] were used to quantify depressive, anxiety, and general psychopathology, respectively.
The Brazilian version of the Barratt Impulsiveness Scale (BIS-11) [23] was used to assess impulsivity. This 30 item self-reported scale has an overall (total) impulsivity score ranging from 30 to 120 points. The scale is also divided into three subscales: Motor Impulsivity (a tendency to act without thinking or considering consequences), Non-planning Impulsivity (characterized as a "present orientation" or a lack of "futuring"), and Attentional Impulsivity (a "cognitive instability" with difficulties in "focusing on the task at hand") [24] .
Descriptive analysis of categorical variables and proportions was performed. Patients were divided into two groups, with and without suicide risk, according to the MINI Plus and were compared by means of univariate and multivariate analyses. For comparison of categorical variables, the χ 2 test and Fisher's exact test were performed; continuous variables were evaluated using the Mann-Whitney U test. Spearman's ρ was used to investigate the correlations between psychopathological scores and to address their colinearity. Logistic regression was conducted to ascertain which variables significantly predicted suicide risk. All these analyses were performed using SPSS Version 15.0; statistical significance was set at the 0.05 level of confidence.
Results
Clinical and sociodemographic features of 66 patients with TLE are summarized in Table 1 . Carbamazepine was the most prescribed drug, taken by 65% of the patients, and benzodiazepines, as a group, were being taken by 47 patients (71%). There were 31 men (47%) and 35 women (53%), and the majority of the sample were not employed (54.5%). Participants had had seizures for an average of 31 years (SD = 12.5), and average age at seizure onset was 9 years (SD = 10.2). Only 2 participants (3%) achieved seizure control for at least 1 year.
Forty-five patients (68.2%) were diagnosed with a lifetime Axis I psychiatric disorder, and 37 (56.1%) presented with a current diagnosis. A lifetime depressive episode was identified in 28 patients (42.4%). Current major depressive disorder was diagnosed in 13 (19.7%) patients. Bipolar disorder was diagnosed in 7 (10.6%), 3 with type I (4.5%) and 4 with type II (6.1%). Four of these patients (6.1%) presented with current bipolar depressive episode and only one patient (1.5%) exhibited a manic state at assessment. Anxiety disorders were observed in 29 (43.9%), psychoses in 3 (4.5%), somatoform disorders in 10 (15.2%), and substance-related disorders in 2 (3%) patients. Of note, some patients had more than one diagnosis. Suicide risk evaluation is described in Table 2 . Table 2 indicates that most patients with suicidality exhibited a low suicide risk (68.4% of the patients with suicide risk). On the other hand, an impressive portion of the sample had a high suicide risk (7.6%), and the majority of patients with increased risk had previously attempted suicide. To evaluate the clinical variables associated with suicide risk the sample was divided into two groups: one group with low or greater suicide risk (MINI Plus suicidality module ≥1 point), and a second group with no suicidality at all (MINI Plus suicidality module = 0). There were no significant statistical differences between groups, with or without suicide risk, in sociodemographic variables (sex, age, ethnic group, marital status, employment), age at onset, duration of the epilepsy, seizure type, mesial temporal sclerosis laterality, number of antiepileptic drugs (AEDs), or use of any AED individually. Frequency of seizures was the only clinical variable that differed statistically between groups (P = 0.012), as patients with suicide risk had a mean (SD) of 8.26 (9.5) seizures/month and those without suicide risk had a mean (SD) of 3.91 (6.7) seizures/month. Table 3 is a psychopathological comparison between groups with and without suicide risk.
Patients with suicide risk manifested higher levels of psychopathology, chiefly depressive symptoms, on BDI scores. Depression was the only psychiatric disorder correlated with suicide risk, though somatoform disorder was also relevant. Additionally, suicide risk was associated with impulsivity. Data described in Table 3 stress that the motor domain is, in fact, the relevant component of impulsivity associated with suicide risk.
The relevance of motor impulsivity to suicide risk is also demonstrated by the positive correlation of the severity of suicide risk scores with the BIS Motor subscale scores (Spearman's ρ = 0.311, P = 0.011), but not with the BIS Total scores or the other BIS subscale scores (P N 0.05, for all). Severity of suicide risk total scores were associated with BDI (Spearman's ρ = 0.471, P b 0.001), HAM-A (Spearman's ρ = 0.347, P = 0.004), and BPRS (Spearman's ρ = 0.323, P = 0.009) scores.
When patients with suicide attempts were compared with those who had never attempted suicide, only lifetime major depression (χ² = 4.7 [1.3-17.2], P = 0.02) and somatoform disorders group (χ² = 5.2 [1.2-21.8], P = 0.03) were statistically significant. It is important to note that depressive symptoms are an important component of somatoform disorders as shown by their association with BDI scores (P b 0.001), and this may explain the association of somatoform disorders with suicide risk. There was no association between suicide attempts and BIS (total or separate subscale) scores.
Logistic regression was conducted to assess whether the predictor variables-current major depression, motor impulsivity, and frequency of seizures-significantly predicted suicide risk. HAM-A and BPRS were excluded from the logistic regression because of the high colinearity with BDI (Spearman's ρ = 0.768 and 0.647, respectively; P b 0.001 for both). BIS Motor scores correlated with psychiatric symptoms measured with the BDI (Spearman's ρ = 0.283, P = 0.021), BPRS (Spearman's ρ =0.410; P = 0.001), and HAM-A (Spearman's ρ = 0.330, P = 0.007). Interestingly, Attentional Impulsivity scores were strongly associated with BDI (Spearman ρ = 0.424, P b 0.001), HAM-A (Spearman's ρ = 0.548, P b 0.001), and BPRS (Spearman ρ =0.363, P = 0.003) scores. Non-planning Impulsivity was not significantly associated with BDI, HAM-A, or BPRS scores (P N 0.1, for all). Table 4 stresses the greater relevance of major depression to suicide risk. Motor impulsivity was also a significant predictor of suicide risk, but not frequency of seizures. Residual analysis showed good fit of the model with the Hosmer Lemeshow test (P =0.744).
A split on motor impulsivity at the median on 21 points (range = 12-35 points) was used to categorize patients into two groups, one with high and the other with low impulsivity. Next, participants were grouped according to the presence of depression and the level of motor impulsivity, and compared with respect to suicide risk, as indicated in Table 5 . The non-depressed/low motor impulsivity group significantly differed with respect to suicide risk when compared with the depressed/low motor impulsivity group (P = 0.038) and, principally, the depressed/high motor impulsivity group (P b 0.001). It is interesting to note that with respect to suicide risk, the non-depressed/low motor impulsivity group did not significantly differ from the non-depressed/high motor impulsivity group (P = 0.247), but the depressed/high motor impulsivity group did statistically differ from the non-depressed/high motor impulsivity group (P = 0.002). No other significant differences were observed between groups.
Discussion
The present data reinforce the idea that neuropsychiatric evaluation in epilepsy must consider suicidality, because in TLE, suicide risk is associated with psychiatric disorders, principally depression. In line with this finding is a population case-control study in Denmark that showed a high risk of suicide among patients with epilepsy and comorbid mood disorder (RR = 19.9, 95% CI = 12.7-31.2, P b 0.0001) [25] . This Danish study analyzed 21,169 cases of suicide and found the highest suicide risk in those with epilepsy and psychiatric comorbidities [25] . A recent Brazilian community-based study also demonstrated the importance of psychiatric disorders in suicidal thoughts, mainly anxiety (3-fold), depression (5-fold), and at least two psychiatric diagnoses (22-fold) [11] .
Depression is the commonest interictal psychiatric disorder in TLE [26, 27] . The importance of treating mental disorders, particularly depression, in epilepsy is emphasized by its association with suicide risk. We observed in this study that major depression was the main variable related to suicide risk and the only psychiatric disorder significantly associated with suicide attempts. Indeed, several recent studies address the relevance of identifying depression in epilepsy [11, 12, 16, 25, 26] , and the Neurological Disorders Depression Inventory for Epilepsy (NDDI-E) [28, 29] stands as a practical screening instrument (takes only about 3 minutes). The NDDI-E was specifically developed to assess depression in epilepsy and also includes one item related to suicidal thoughts ("I'd be better off dead").
Abnormal serotonergic neurotransmission is demonstrated in depression as well as in TLE and suicide [30, 31] . It is suggested that common underlying pathways may link depression, suicide, and epilepsy [1, [32] [33] [34] . A low serotonergic state is linked to aggressive-impulsive behaviors [7] , and impulse control disorders are usually treated with serotonergic drugs [35] . A FDG-PET study showed clinical improvement and increased PFC metabolism in aggressive-impulsive patients treated with a selective serotonin reuptake inhibitor [36] . Studies conducted in rodents revealed that serotonergic dysfunction in PFC can affect inhibitory response control [35] . Furthermore, perseverative and inflexible behaviors, such as impaired error detection and inappropriate reactions to punishment or loss of reward, are associated with low serotonin in PFC [37] . Thus, serotonergic dysfunction and frontal lobe dysfunction are possible neurobiological underpinnings related to depression and impulsivity leading to suicidal behavior in TLE.
Frontal lobe dysfunction can be seen in TLE, and a role for PFC in impulsivity, depression, and suicide has been proposed. Bilateral reduction in prefrontal metabolism is described in children with TLE with aggressive behavior [38] and depressed patients with complex partial seizures [39] . Raust et al. compared 30 euthymic suicidal patients with 39 control subjects and found that BIS Motor Impulsivity scores, but not BIS Total or other BIS subscale scores, were significantly higher in the former group [8] . These authors point to dysexecutive problems in patients with suicidal behavior who showed impairment on cognitive domains such as visuospatial conceptualization, inhibitory control, and visual attention (or reading fluency), even after adjustment for motor impulsivity as a covariate [8] . A high prevalence (29%) of impulse control disorders was reported in a sample of severely depressed patients who exhibited higher Motor Impulsivity scores than those without impulse control disorders, according to the BIS [9] . A higher risk of suicide in patients with TLE with perseverative responses on the Wisconsin Card Sorting Test was also described, suggesting the role of executive dysfunction in suicide risk [12] . Impairment on conceptual flexibility and problem solving, in a context of negative thoughts, may lead to a poor ability to select the appropriate social adaptation in different adversities faced by people with epilepsy [12] , leading to frustration and suicidal ideation.
On the basis of our results, depression showed an association with impulsivity, mainly attentional but also motor impulsivity. In fact, an association between attentional impulsivity and depression and mania was previously described in bipolar patients, showing that impulsivity could be an element of mood disorders itself [40] . Additionally, motor impulsivity correlates with mania in bipolar disorder [40] . Hence it is plausible that negative affect associated with a cognitive vulnerability, characterized by impairment in motor inhibitory control and the tendency to act on the spur of the moment, may lead to suicidal behaviors in patients with TLE.
Attention-deficit/hyperactivity disorder (ADHD) is an important disorder related to pathological impulsivity [35] . However, ADHD diagnosis requires information about childhood behavior, and a significant portion of the sample had memory deficits, especially common in TLE, or was without a caregiver who could provide reliable information, limiting the diagnosis of this disorder. To avoid selection biases, ADHD diagnosis was not described and this is one of the limitations of the present study. By the same token, considering that it was difficult to obtain complete information about the past history of some patients, including child behavior, some diagnosis such as depression, bipolar disorder, or impulsivity during childhood could have been omitted, underestimating the lifetime diagnoses described in this study.
There are other particular suicide risk factors in epilepsy such as epilepsy type, localization, lateralization, and age at onset, as well as stigma, psychosocial impact, peri-ictal behavior, and adverse effects of AEDs on mood [12] . In our study, patients with suicide risk had a higher frequency of seizures in the univariate analysis, but this did not survive the logistic regression. This can be interpreted as a possible indirect association of seizure frequency with depressive disorders, as refractory epilepsy is related to a high frequency of depression [41] . It seems likely that adequate control of seizures can contribute to the prevention of depression and, consequently, reduction in suicide risk [42] . In fact, clinical variables associated with epilepsy, such as high seizure frequency, early onset, AED polytherapy, and also a major depression history, are described as the typical findings in people with epilepsy who commit suicide. Suicide risk and violent suicidal methods are probably related to a history of depression [3, 12] . The importance of dysphoric mood was described in 5 suicides registered among more than 10,000 patients of a North American specialized epilepsy center [43] . Interestingly, all 5 patients had undergone surgical treatment for epilepsy (3 had right temporal lobectomy), and the authors suggested that suicidality may be related to seizure control after longstanding epilepsy [43] . Kanner et al. described postictal suicidal thoughts in 13% (no suicide attempt) of 100 consecutive patients with refractory partial epilepsy. Not surprisingly, 77% of these patients with suicide ideation had a history of depressive episodes [44] .
It is worth noting that a history of suicide attempts is the most important predictor of suicide, as more than one-third of people with a positive history attempt suicide again [1] . A Scandinavian populationbased study found that 46.2% of people with epilepsy who committed suicide had previously attempted suicide [45] , which suggests that attention must be paid to subjects with a history of suicide attempts, as in 23.3% of the present study sample, especially those with high suicide risk (6.1%).
Lately, the role of AEDs in suicide has been debated. Based on a meta-analysis conducted in 2008, the Food and Drug Administration issued a warning about the risk of suicide and the use of 11 AEDs, though only topiramate and lamotrigine reached statistical significance. This warning has been subject to criticism as most of the studies involved patients in polytherapy, ignoring the relevance of drug interactions among AEDs [1] . Data described here showed no association between the number of AEDs or the use of any specific AED and suicide risk. Further, off-label studies showed that AEDs such as carbamazepine, valproate, and phenytoin can be effective in reducing impulsivity, mainly associated with aggressive behavior [7, 46, 47] , and thus could be useful in clinical practice to minimize impulsive behaviors related to suicide. However, though some AEDs can have a positive impact on mood (e.g., lamotrigine), others are associated with depression (e.g., ethosuximide, topiramate, vigabatrin, and rufinamide) [46] , and this should be taken into account in the neuropsychiatric evaluation of suicide risk in epilepsy.
Our findings are limited by the sample size and selection bias toward refractory TLE and must be seen in a context of a hospital setting which includes people with more severe epilepsy and possibly higher suicide risk. The absence of a control group and lack of information about the neuropsychological profile are other limitations of the present study. Our data support the concept of a strong association between suicide and depression in TLE. Common neurophysiological mechanisms may lead to a low serotonin input into the PFC in depression, epilepsy and deficits in cognitive inhibition, all increasing the risk of suicidal and impulsive behavior. Suicidal risk in epilepsy is determined by a complex combination of different factors such as psychopathology (especially Table 5 Suicidality regarding depression and motor impulsivity (N = 66).
Non-depressed Depressed
With low motor impulsivity (n = 25)
With high motor impulsivity (n = 24)
With low motor impulsivity (n = 6)
With high motor impulsivity (n = 11) mood background), cognitive flexibility, inhibitory control, personality traits, problem-solving abilities, psychosocial stressors, and severity of seizures, among others. Therefore, patients must be assessed individually, weighing how much each variable accounts for suicide risk. Suicide prevention in this group is the most important reason for reducing suicidality, especially looking after the most vulnerable group, patients with past suicide attempts. Simultaneously, early diagnosis and treatment of depression constitute an obvious strategy.
Conclusion
Whereas history of suicide attempt is the strongest risk factor for suicide, depression is the most important psychiatric condition associated with suicide risk in TLE. Motor impulsivity seems to be a relevant component of suicidality in TLE. Notwithstanding, our data suggest that impulsivity may be secondarily related to psychiatric symptoms, more specifically depression. These data reinforce the relevance of diagnosing and treating depression appropriately in epilepsy. We hypothesize that impairment in executive functioning may underlie suicidality in patients with depression and motor impulsivity traits in TLE. Psychiatric evaluation must draw special attention to mood, cognition (executive functioning), and impulsivity when addressing suicide in TLE.
